Alshaer, M., Babel, H., Engelhardt, B., Burns, M. C., Pang, Y., Parikh, A. (2026). Exposure-response analyses from a randomized dose optimization study of telisotuzumab adizutecan (Temab-A) in combination with bevacizumab in patients with metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.132